Multimodality Imaging in the Evaluation of Intracardiac Masses

  • Carolyn M. Wu
  • Peter J. Bergquist
  • Monvadi B. SrichaiEmail author
Imaging (Q Truong, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Imaging


Intracardiac masses are classified as neoplastic or non-neoplastic. Prognosis varies based on the diagnosis of the mass since treatment options differ greatly. As novel imaging techniques emerge, a multimodality approach to the evaluation of intracardiac masses becomes an important part of non-invasive evaluation prior to potential surgical planning or oncological treatment. The purpose of this article is to compare the available imaging modalities—echocardiography, cardiovascular magnetic resonance, cardiac computed tomography, nuclear imaging, and emerging novel hybrid imaging techniques for future clinical applications—and to review the characteristic features seen on those modalities for the most common intracardiac masses.


Intracardiac masses Multimodality imaging Cardiac MRI Cardiac CT Echocardiography Positron emission tomography 


Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Lam KY, Dickens P, Chan ACL. Tumors of the heart: a 20-year experience with a review of 12,485 consecutive autopsies. Arch Pathol Lab Med. 1993;117:1027–31.PubMedGoogle Scholar
  2. 2.
    Pazos-López P, Pozo E, Siqueira ME, García-Lunar I, Cham M, Jacobi A, et al. Value of CMR for the differential diagnosis of cardiac masses. JACC Cardiovasc Imaging. 2014;7:896–905. Scholar
  3. 3.
    Gupta S, Plein S, Greenwood JP. The Coumadin Ridge: an important example of a left atrial pseudotumour demonstrated by cardiovascular magnetic resonance imaging. J Radiol Case Rep. 2009;3:1–5. Scholar
  4. 4.
    Burke A, Tavora F. The 2015 WHO Classification of tumors of the heart and pericardium. J Thorac Oncol. 2016;11:441–52. Scholar
  5. 5.
    Lang RM, Goldstein SA, Kronzon I, Khandheria BK, Mor-Avi V, American Society of Echocardiography. ASE’s comprehensive echocardiography 2015.Google Scholar
  6. 6.
    Mügge A, Daniel WG, Haverich A, Lichtlen PR. Diagnosis of noninfective cardiac mass lesions by two-dimensional echocardiography. Comparison of the transthoracic and transesophageal approaches. Circulation. 1991;83:70–8.CrossRefPubMedGoogle Scholar
  7. 7.
    Reeder GS, Khandheria BK, Seward JB, Tajik AJ. Transesophageal echocardiography and cardiac masses. Mayo Clin Proc. 1991;66:1101–9. Scholar
  8. 8.
    •• Mankad R, Herrmann J. Cardiac tumors: echo assessment. Echo Res Pract. 2016;3:R65–77. Comprehensive echocardiographic evaluation of the most common cardiac masses in detail with algorithms.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Kirkpatrick JN, Wong T, Bednarz JE, Spencer KT, Sugeng L, Ward RP, et al. Differential diagnosis of cardiac masses using contrast echocardiographic perfusion imaging. J Am Coll Cardiol. 2004;43:1412–9. Scholar
  10. 10.
    Asch FM, Bieganski SP, Panza JA, Weissman NJ. Real-time 3-dimensional echocardiography evaluation of intracardiac masses. Echocardiography. 2006;23:218–24. Scholar
  11. 11.
    Plana JC. Added value of real-time three-dimensional echocardiography in assessing cardiac masses. Curr Cardiol Rep. 2009;11:205–9. Scholar
  12. 12.
    Ganame J, D’hooge J, Mertens L. Different deformation patterns in intracardiac tumors. Eur J Echocardiogr. 2005;6:461–4. Scholar
  13. 13.
    • Palaskas N, Thompson K, Gladish G, Agha AM, Hassan S, Iliescu C, et al. Evaluation and management of cardiac tumors. Curr Treat Options Cardiovasc Med. 2018;20:29. Provides overview of multimodality evaluation and management of common cardiac tumors.CrossRefPubMedGoogle Scholar
  14. 14.
    Greenwood JP, Motwani M, Crean AM. Cardiac tumours. Adv Card Imaging. 2015:585–616.,242-282-2.00017-2.
  15. 15.
    Finn JP, Nael K, Deshpande V, Ratib O, Laub G. Cardiac MR imaging: state of the technology. Radiology. 2006;241:338–54. Scholar
  16. 16.
    Altbach MI, Squire SW, Kudithipudi V, Castellano L, Sorrell VL. Cardiac MRI is complementary to echocardiography in the assessment of cardiac masses. Echocardiography. 2007;24:286–300. Scholar
  17. 17.
    Patel R, Lim RP, Saric M, Nayar A, Babb J, Ettel M, et al. Diagnostic performance of cardiac magnetic resonance imaging and echocardiography in evaluation of cardiac and paracardiac masses. Am J Cardiol. 2016;117:135–40. Scholar
  18. 18.
    Mousavi N, Cheezum MK, Aghayev A, Padera R, Vita T, Steigner M, et al. Assessment of cardiac masses by cardiac magnetic resonance imaging: histological correlation and clinical outcomes. J Am Heart Assoc 2019;8. doi:
  19. 19.
    •• Doherty JU, Kort S, Mehran R, Schoenhagen P, Soman P, Dehmer GJ, et al. ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 Appropriate use criteria for multimodality imaging in the assessment of cardiac structure and function in nonvalvular heart disease. J Am Coll Cardiol. 2019;73:488–516. Appropriate use criteria for multimodality imaging, statement from major cardiology societies.CrossRefPubMedGoogle Scholar
  20. 20.
    Taylor AJ, Cerqueira M, Hodgson JMB, Mark D, Min J, O’Gara P, et al. ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 Appropriate use criteria for cardiac computed tomography. J Cardiovasc Comput Tomogr. 2010;4:407.e1–407.e33. Scholar
  21. 21.
    Hong YJ, Hur J, Han K, Im DJ, Suh YJ, Lee HJ, et al. Quantitative analysis of a whole cardiac mass using dual-energy computed tomography: comparison with conventional computed tomography and magnetic resonance imaging. Sci Rep. 2018;8:15334.,635-0.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Hong YJ, Hur J, Kim YJ, Lee HJ, Hong SR, Suh YJ, et al. Dual-energy cardiac computed tomography for differentiating cardiac myxoma from thrombus. Int J Card Imaging. 2014;30:121–8. Scholar
  23. 23.
    Saponara M, Ambrosini V, Nannini M, Gatto L, Astolfi A, Urbini M, et al. 18F-FDG-PET/CT imaging in cardiac tumors: illustrative clinical cases and review of the literature. Ther Adv Med Oncol. 2018;10:1–9. Scholar
  24. 24.
    Rahbar K, Seifarth H, Schafers M, Stegger L, Hoffmeier A, Spieker T, et al. Differentiation of malignant and benign cardiac tumors using 18F-FDG PET/CT. J Nucl Med. 2012;53:856–63. Scholar
  25. 25.
    Nensa F, Tezgah E, Poeppel TD, Jensen CJ, Schelhorn J, Kohler J, et al. Integrated 18F-FDG PET/MR imaging in the assessment of cardiac masses: a pilot study. J Nucl Med. 2015;56:255–60. Scholar
  26. 26.
    Kuester LB, Fischman AJ, Fan CM, Halpern EF, Aquino SL. Lipomatous hypertrophy of the interatrial septum: prevalence and features on fusion 18F fluorodeoxyglucose positron emission tomography/CT. Chest. 2005;128:3888–93. Scholar
  27. 27.
    Wibmer AG, Hricak H, Ulaner GA, Weber W. Trends in oncologic hybrid imaging. Eur J Hybrid Imaging. 2018;2:1. Scholar
  28. 28.
    Krumm P, Mangold S, Gatidis S, Nikolaou K, Nensa F, Bamberg F, et al. Clinical use of cardiac PET/MRI: current state-of-the-art and potential future applications. Jpn J Radiol. 2018;36:313–23. Scholar
  29. 29.
    Feinberg DA, Giese D, Bongers DA, Ramanna S, Zaitsev M, Markl M, et al. Hybrid ultrasound MRI for improved cardiac imaging and real-time respiration control. Magn Reson Med. 2010;63:290–6. Scholar
  30. 30.
    Nensa F, Bamberg F, Rischpler C, Menezes L, Poeppel TD, la Fougère C, et al. Hybrid cardiac imaging using PET/MRI: a joint position statement by the European Society of Cardiovascular Radiology (ESCR) and the European Association of Nuclear Medicine (EANM). Eur Radiol. 2018;28:4086–101. Scholar
  31. 31.
    Abels B, Pfeiffer S, Stix J, Schwab J. Multimodal imaging for the assessment of a cardiac mass—a case of primary cardiac sarcoma. J Radiol Case Rep. 2017;11:11–9. Scholar
  32. 32.
    O’Donnell DH, Abbara S, Chaithiraphan V, Yared K, Killeen RP, Cury RC, et al. Cardiac tumors: optimal cardiac MR sequences and spectrum of imaging appearances. Am J Roentgenol. 2009;193:377–87. Scholar
  33. 33.
    Barkhausen J, Hunold P, Eggebrecht H, Schüler WO, Sabin GV, Erbel R, et al. Detection and characterization of intracardiac thrombi on MR imaging. Am J Roentgenol. 2002;179:1539–44. Scholar
  34. 34.
    Hur J, Pak HN, Kim YJ, Lee HJ, Chang HJ, Hong YJ, et al. Dual-enhancement cardiac computed tomography for assessing left atrial thrombus and pulmonary veins before radiofrequency catheter ablation for atrial fibrillation. Am J Cardiol. 2013;112:238–44. Scholar
  35. 35.
    Możeńska O, Sypuła S, Celińska-Spoder M, Walecki J, Kosior DA. Mitral annulus caseous calcification mimicking cardiac mass in asymptomatic patient—multimodality imaging approach to incidental echocardiographic finding. Pol J Radiol. 2014;79:88–90. Scholar
  36. 36.
    Colin GC, Gerber BL, Amzulescu M, Bogaert J. Cardiac myxoma: a contemporary multimodality imaging review. Int J Card Imaging. 2018;34:1789–808. Scholar
  37. 37.
    Burke AP, Virmani R. Cardiac myxoma. A clinicopathologic study. Am J Clin Pathol. 1993;100:671–80. Scholar
  38. 38.
    Goldberg HP, Glenn F, Dotter CT, Steinberg I. Myxoma of the left atrium; diagnosis made during life with operative and post-mortem findings. Circulation. 1952;6:762–7.CrossRefPubMedGoogle Scholar
  39. 39.
    Handke M, Goepfrich M, Keller H. Strongly neovascularized left atrial myxoma. Eur J Echocardiogr. 2008;9:99–100. Scholar
  40. 40.
    Engberding R, Daniel WG, Erbel R, Kasper W, Lestuzzi C, Curtius JM, et al. Diagnosis of heart tumours by transoesophageal echocardiography: a multicentre study in 154 patients. Eur Heart J. 1993;14:1223–8. Scholar
  41. 41.
    Abbas A, Garfath-Cox KAG, Brown IW, Shambrook JS, Peebles CR, Harden SP. Cardiac MR assessment of cardiac myxomas. Br J Radiol. 2015;88:20140599. Scholar
  42. 42.
    Motwani M, Chb MB, Kidambi A, Bch BM, Herzog BA, Uddin A, et al. MR imaging of cardiac tumors and masses: a review of methods and clinical applications 2013;268:26–43.Google Scholar
  43. 43.
    Gheysens O, Cornillie J, Voigt JU, Bogaert J, Westhovens R. Left atrial myxoma on FDG-PET/CT. Clin Nucl Med. 2013;38:e421–2. Scholar
  44. 44.
    McAllister HA, Hall RJ, Cooley DA. Tumors of the heart and pericardium. Curr Probl Cardiol. 1999;24:59–116. Scholar
  45. 45.
    Gowda RM, Khan IA, Nair CK, Mehta NJ, Vasavada BC, Sacchi TJ. Cardiac papillary fibroelastoma: a comprehensive analysis of 725 cases. Am Heart J. 2003;146:404–10. Scholar
  46. 46.
    Bass JL, Breningstall GN, Swaiman KF. Echocardiographic incidence of cardiac rhabdomyoma in tuberous sclerosis. Am J Cardiol. 1985;55:1379–82. Scholar
  47. 47.
    Grebenc ML, Rosado de Christenson ML, Burke AP, Green CE, Galvin JR. Primary cardiac and pericardial neoplasms: radiologic-pathologic correlation. Radiographics. 2000;20:1073–103. Scholar
  48. 48.
    Buckley O, Madan R, Kwong R, Rybicki FJ, Hunsaker A. Cardiac masses, part 2: key imaging features for diagnosis and surgical planning. Am J Roentgenol. 2011;197:W842–51. Scholar
  49. 49.
    Shapiro LM. Cardiac tumours: diagnosis and management. Heart. 2001;85:218–22. Scholar
  50. 50.
    Kojima S, Sumiyoshi M, Suwa S, Tamura H, Sasaki A, Kojima T, et al. Cardiac hemangioma: a report of two cases and review of the literature. Heart Vessel. 2003;18:153–6. Scholar
  51. 51.
    Papadopoulos K, Makrides CA, Eleutheriou E. A cardiac haemangioma: the contribution of myocardial contrast echocardiography in the diagnosis. BMJ Case Rep. 2015;2015:bcr2015210075.,075.CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Kiaffas MG, Powell AJ, Geva T. Magnetic resonance imaging evaluation of cardiac tumor characteristics in infants and children. Am J Cardiol. 2002;89:1229–33. Scholar
  53. 53.
    Oshima H, Hara M, Kono T, Shibamoto Y, Mishima A, Akita S. Cardiac hemangioma of the left atrial appendage: CT and MR findings. J Thorac Imaging. 2003;18:204–6.,307,000-00012.CrossRefPubMedGoogle Scholar
  54. 54.
    Cresti A, Chiavarelli M, Munezero Butorano MA, Franci L. Multimodality imaging of a silent cardiac hemangioma. J Cardiovasc Echogr. 2015;25:31. Scholar
  55. 55.
    Hudzik B, Miszalski-Jamka K, Glowacki J, Lekston A, Gierlotka M, Zembala M, et al. Malignant tumors of the heart. Cancer Epidemiol. 2015;39:665–72. Scholar
  56. 56.
    Vander Salm TJ. Unusual primary tumors of the heart. Semin Thorac Cardiovasc Surg. 2000;12:89–100. Scholar
  57. 57.
    Kupsky DF, Newman DB, Kumar G, Maleszewski JJ, Edwards WD, Klarich KW. Echocardiographic features of cardiac angiosarcomas: the Mayo Clinic experience (1976–2013). Echocardiography. 2016;33:186–92. Scholar
  58. 58.
    Dorsay TA, Ho VB, Rovira MJ, Armstrong MA, Brissette MD. Primary Cardiac lymphoma: CT and MR findings. J Comput Assist Tomogr. 1993;17:978–81.CrossRefPubMedGoogle Scholar
  59. 59.
    Ciancarella P, Fusco A, Citraro D, Sperandio M, Floris R. Multimodality imaging evaluation of a primary cardiac lymphoma. J Saudi Heart Assoc. 2017;29:128–35. Scholar
  60. 60.
    Jhanwar YS, Straus DJ. The role of PET in lymphoma. J Nucl Med. 2006;47:1326–34.PubMedGoogle Scholar
  61. 61.
    Al-Mamgani A, Baartman L, Baaijens M, De Pree I, Incrocci L, Levendag PC. Cardiac metastases. Int J Clin Oncol. 2008;13:369–72. Scholar
  62. 62.
    Reynen K, Köckeritz U, Strasser RH. Metastases to the heart. Ann Oncol. 2004;15:375–81. Scholar
  63. 63.
    • Lichtenberger JP, Reynolds DA, Keung J, Keung E, Carter BW. Metastasis to the heart: a radiologic approach to diagnosis with pathologic correlation. Am J Roentgenol. 2016;207:764–72. Comprehensive review of metastasis to the heart.CrossRefGoogle Scholar
  64. 64.
    Agha AM, Lopez-Mattei J, Donisan T, Balanescu D, Iliescu CA, Banchs J, et al. Multimodality imaging in carcinoid heart disease. Open Heart. 2019;6:e001060. Scholar
  65. 65.
    Haugaa KH, Bergestuen DS, Sahakyan LG, Skulstad H, Aakhus S, Thiis-Evensen E, et al. Evaluation of right ventricular dysfunction by myocardial strain echocardiography in patients with intestinal carcinoid disease. J Am Soc Echocardiogr. 2011;24:644–50. Scholar
  66. 66.
    Gabriel M, Decristoforo C, Kendler D, Dobrozemsky G, Heute D, Uprimny C, et al. 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT. J Nucl Med. 2007;48:508–18. Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Carolyn M. Wu
    • 1
  • Peter J. Bergquist
    • 2
  • Monvadi B. Srichai
    • 1
    • 2
    Email author
  1. 1.Department of CardiologyMedStar Georgetown University Hospital, MedStar Washington Hospital Center, MedStar Heart and Vascular InstituteWashingtonUSA
  2. 2.Department of Radiology & Department of RadiologyMedstar Georgetown University HospitalWashingtonUSA

Personalised recommendations